Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
entacopone study
we have just been offered more openings in our ongoing entacapone study. Entacappone is a COMT inhibitor which is effective as an adjunct to sinemet to help control motor fluctuations. Patints who do not have too much dyskinesia are best for this trial. If you live live near Los Angeles and are interested in being considered for this study ,call Mickie at 213-342-5814.
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance